Zarbeil Syrup 150 ml FR

Nom de l'organisation

Labomar S.p.A.

SRN

IT-MF-000007965

Statut du fabricant

Actif

Santé des certificats sur le portefeuille de ce fabricant.

1 avertissement enregistré — faire défiler le panneau pour tout voir.

• CW999

  Do not administer the product to children under two years of age. In children aged two years, if symptoms persist and worsen after first two days of treatment, consult your doctor. If you do not notice appreciable results after a short period of treatment (7 days), contact your doctor, in any case do not use for more than 15 days. Do not take it if you are allergic, intolerant or hypersensitive to any component. Do not use the product after the expiry date printed on the package. Keep out of the reach of children. Do not use for purposes other than that for which the product is intended. If you or your child experiences side effects, inform your doctor. Expiry date refers to the product in its intact packaging, and properly stored. Since no data on use in pregnancy and breastfeeding are available, its use is not recommended. If you are pregnant or breastfeeding, consult a doctor before use. Do not use in case the package is not intact. The period of validity after the first opening of the syrup is 3 months. Any serious incident that occurs in relation to the device should be reported to the manufacturer and the Competent Authority. In case of any undesired event always seek for medical advice.

Marché principal en France ; disponible dans 1 pays au total.

Dénomination commerciale

Zarbeil Syrup 150 ml FR

Code d'UDI-DI

08056300620631

Basic UDI-DI

805630062FTPR101DK

Numéro de référence/catalogue

FTPR101

Entité d'attribution

GS1

Catégorie de risque

Classe IIa

Législation applicable

MDR [Règlement (UE) 2017/745 relatif aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

Zarbeil Syrup is a medical device composed of substances, not sterile, intended for short term invasive contact with respect to body orifices (oral cavity), designed for the treatment of productive and dry cough in children (2+), adolescents and adults.

URL des informations complémentaires

https://labomar.com/en/products/ftpr-101-b/

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• V9017ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES